The Inspire Sleep Apnea Implant is a medical device that’s implanted into the body for the treating snoring and obstructive sleep apnea (OSA) syndrome.
Obstructive ANTI SNORING Syndrome
Obstructive anti snoring syndrome is a disease due to relapsing episodes of anti snoring. It is a condition where breathing stops for more than 10 seconds, during which oxygen saturation in the blood is reduced by more than 4%.
OSA syndrome occurs while asleep, once the muscles of upper airways relax, evoking the obstruction of the respiratory tract. This results in deterioration of blood oxygenation and provokes short unconscious wake-up episodes through the entire night. An unhealthy pattern of sleep places pressure on the body, causing increased blood circulation pressure and development of severe diseases. The diseases due to OSA can be physical, such as hypertension, myocardium infarction and stroke. They could also be mental, including depression, chronic fatigue syndrome, lack of memory and concentration.
Before any treatment, a sleep study or perhaps a polysomnography is necessary. The polysomnography calculates the apnea index, that is the frequency of apnea episodes during 1 hour of sleep and determines the severity of the disease. The apnea index is considered significant if there are a lot more than 20 apnea episodes per hour, whatever the presence or absence of clinical symptoms.
The gold standard of treatment for OSA syndrome is CPAP-therapy. However, CPAP therapy isn’t for everyone as many people find it uncomfortable to sleep with the mask on the face and the machine itself could be loud, especially since it commonly sits near the head. Only 25% of patients may use CPAP-therapy for a long period of time.
Therefore, recently Inspire Medical Systems Inc. has think of a very effective solution with the Inspire Sleep Apnea Implant.
How The Inspire Sleep Apnea Implant Works
The Inspire ANTI SNORING Implant is a battery operated device that promotes electrostimulation of the sublingual nerve. The battery life is approximately a decade.
The main unit of this device is placed under the skin, on the front right side of the chest and it monitors the phase of breathing. Another electrode is implanted for stimulation of the sublingual nerve, which creates muscle tension. This opens top of the airways and allows the tongue to stand out, and helps maintain the airways open while asleep.
In addition to the two electrodes, this device also includes a handy small remote switch, which actually turns on the device before sleep and switches it off once awake. This disables the electrodes from disturbing the processes of communication and eating through the active phase of your day, whenever a person needs physiological narrowing of the larynx and tongue movements for these processes.
The individual may feel light involuntary contractions of the larynx, or tongue movements during initial usage of these devices. These movements usually do not cause pain, instead only a minor discomfort. These unpleasant effects disappear following the first few uses of these devices.
Generally, the implant should be checked 1 or 2 2 times each year. However, depending on the situation, an Inspire therapy-trained doctor may consult patients pretty much often.
The Inspire Sleep Apnea Implant is only suitable for:
Patients who are a lot more than 22 years old.
Patients who have been diagnosed with moderate or severe obstructive sleep apnea syndrome.
Patients having an apnea index in the number of 20 to 65.
Patients who are uncomfortable with using CPAP therapy or did not have the desired effect.
Patients with a body mass index of significantly less than 32.
Body mass index (BMI) = weight (kg) / height^2 (m2).
An individual with a weight of 80 kg and a height of 170 cm has
BMI = 80kg / (1.7m ^ 2) = 80 / 2.89 = 27.68 kg/ m2
The Inspire Sleep Apnea Implant could potentially replace CPAP therapy as ‘the gold standard’ of treatment for obstructive sleep apnea syndrome. A study by Dr. Ryan J. et al. shows that after implantation of the Inspire ANTI SNORING Implant, snoring is greatly decreased. A percentage of “no” or “soft” snoring changed from 22% at start of the treatment to 88% at 12 months and 91% at 24 months following the treatment. ufabet Also, the apnea index was reduced from 31 to 14. 82% of the patients in the analysis reported a nightly usage of this therapy for five years. Therefore, it really is evident that this method is highly effective and simple to use!